University of Texas MD Anderson Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2019

  1. YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

    American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899

2012

  1. Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: A systematic review

    European Archives of Oto-Rhino-Laryngology, Vol. 269, Núm. 4, pp. 1073-1083